Truscreen Group Ltd NZX:TRU:
KEY MARKETS UPDATE
UZBEKISTAN FIRST SALES CONTRACT SIGNED
EXPANDS DISTRIBUTION TO ROMANIA AND ITALY
Truscreen Group Says It Signed First Uzbekistan Sales Contract
Earlier from TruScreen
- TRU: Revenue down 17% in 1H FY2026, but growth expected from new programs and markets
- TRU: FY26 growth is forecast on public program expansion, new markets, and product diversification
- TRU: FY26 sales projected to surpass NZ$2.8m as public programs and new markets accelerate growth
- ASX Investment Opportunities on Show in Singapore During Grand Prix
- TRU: Revenue fell 15.7% and net loss increased to $2.24 million, with material going concern uncertainty
Later from TruScreen
- TruScreen Validated as Superior Cervical Cancer Screening Tool in Major Chinese Study
- Truscreen Group Provides Management Update
- Truscreen Group Sees Total Revenue For Fy2026 To Be Nz$2.7 Million
- Truscreen Says Submits Three Proposals To Unitaid's Global Cervical Cancer Elimination Call
- Truscreen Group Sees FY26 Unaudited Loss
Follow TruScreen into a list and get an email when it puts out news.
Follow TruScreen